The effect of high doses of 5-hydroxytryptophan on a patient with trisomy 21. Clinical, chemical and EEG correlations.
D006916:5-Hydroxytryptophan / Q000008:administration & dosage / Q000494:pharmacology*; D000367:Age Factors; D002490:Central Nervous System / Q000187:drug effects*; D002904:Chromosomes, Human, 21-22 and Y; D004314:Down Syndrome / Q000188:drug therapy*; D004569:Electroencephalography; D005071:Evoked Potentials / Q000187:drug effects*; D005260:Female; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000097:blood / Q000652:urine; D007223:Infant; D007231:Infant, Newborn; D008027:Light; D009069:Movement Disorders; D009622:Noise; D011581:Psychological Tests; D012890:Sleep / Q000187:drug effects; D012895:Sleep, REM / Q000187:drug effects; D014313:Trismus / Q000188:drug therapy
D006897:Hydroxyindoleacetic Acid; D006916:5-Hydroxytryptophan